# US 2006/0155190 A1 · Imageable biopsy site marker

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0155190 A1
- Document ID: US20060155190A1
- Status: Published application
- Kind: A1
- Application number: 11/366,956
- Filed: 2006-03-02
- Published: 2006-07-13
- Earliest claimed: 1999-02-02
- Assignees: SenoRx, Inc.
- Inventors: Fred Burbank; Paul Lubock; Michael Jones; Nancy Forcier
- Web page: https://patentgrep.com/patent/US20060155190A1

## CPC

- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61K 49/006: {Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery}
- A61M 37/0069: {Devices for implanting pellets, e.g. markers or solid medicaments (for introducing of radioactive sources for interstitial radiation therapy, i.e. brachytherapy A61N5/1027)}
- A61B 10/02: Instruments for taking cell samples or for biopsy {(A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48)}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2090/3788: {transmitter only}
- A61B 2090/3908: {Soft tissue, e.g. breast tissue}
- A61B 2090/3925: {ultrasonic}
- A61B 2090/3929: {Active markers}
- A61B 2090/3933: {Liquid markers}
- A61B 2090/395: {with marking agent for marking skin or other tissue}
- A61B 2090/3975: {active}
- A61B 2090/3987: {Applicators for implanting markers}
- A61B 2090/3995: {Multi-modality markers}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A biopsy site marker having at least one small marker body or pellet of bioresorbable material such as gelatin, collagen, polylactic acid, polyglycolic acid which has a radiopaque object, preferably with a non-biological configuration. The at least one bioresorbable body or pellet with a radiopaque object is deposited into the biopsy site, by an delivery device that includes an elongated tubular body with a piston slidable within the tubular body. One end of the tube is placed into the biopsy site. At least one but preferably several marker bodies or pellets are deposited sequentially into the biopsy site through the tube. At least the bioresorbable materials of the detectable markers remain present in sufficient quantity to permit detection and location of the biopsy site at a first time point (e.g., 2 weeks) after introduction but clear from the biopsy site or otherwise do not interfere with imaging of tissues adjacent the biopsy site at a second time point (e.g., 5-7 months) after introduction.

## Claims

### Claim 1

A target tissue localization device comprising: an elongate tubular member having a proximal end, a distal end, and a lumen therebetween, a plurality of bioabsorbable bodies disposed in the lumen and at least one of the bioresorbable bodies within the inner lumen having a radiographically detectable marker with a non-natural shape.

### Claim at position 2

2-57. (canceled)

### Claim 58

A target tissue localization device comprising:
an elongate tubular member having a proximal end, a distal end, and a lumen therebetween;
a bioresorbable body contained within the elongate tubular member, the bioresorbable body comprising gelatin;
a radiographically detectable marker carried by the body.

### Claim 59 (depends on 58)

The target tissue localization device of claim 58, wherein the bioresorbable body is remotely visualizable by at least one of ultrasound and mammography.

### Claim 60 (depends on 58)

The target tissue localization device of claim 58, wherein the radiopaque marker is contained within the bioresbrbable body.

### Claim 61 (depends on 58)

The target tissue localization device of claim 58, wherein the bioresorbable body comprises at least one bioresorbable body.

### Claim 62 (depends on 58)

The target tissue localization device of claim 58, wherein the bioresorbable body swells upon contact with body fluid.

### Claim 63 (depends on 5)

The target tissue localization device of claim 5, wherein the bioresorbable body swells to substantially fill the biopsy site.

### Claim 64

A method for marking a biopsy cavity comprising the steps of: providing a bioresorbable body having a radiopaque marker carried by the bioresorbable body, said bioresorbable body comprising gelatin; removing a biopsy specimen from the breast of a patient, thereby creating a biopsy site; inserting the bioresorbable body into the biopsy site to mark the location of the biopsy site; and testing the biopsy specimen.

### Claim 65 (depends on 64)

The method of claim 64, further comprising the step of relocating the biopsy site by detecting the radiopaque marker.

### Claim 66 (depends on 64)

The method of claim 64, wherein the bioresorbable body comprises at least one bioresorbable body.

### Claim 67 (depends on 64)

The method of claim 64, wherein the radiopaque marker is contained within the bioresorbable body.

### Claim 68 (depends on 65)

The method of claim 65, wherein the radiopaque marker is detected by mammography.

### Claim 69 (depends on 65)

The method of claim 65, wherein the radiopaque marker is detected by ultrasound.

### Claim 70 (depends on 64)

The method of claim 64, wherein the bioresorbable body swells upon contact with body fluid.

### Claim 71 (depends on 64)

The method of claim 64, wherein the bioresorbable body swells to substantially fill the biopsy site.

### Claim 72

A target tissue localization device comprising: an elongate tubular member having a proximal end, a distal end, and a lumen therebetween; a bioresorbable body contained within the elongate tubular member, the bioresorbable body comprising polylactic acid; and a radiopaque marker carried by the bioresorbable body.

### Claim 73 (depends on 72)

The target tissue localization device of claim 72, wherein the bioresorbable body further comprises polyglycolic acid.

### Claim 74

A method for marking a biopsy cavity comprising the steps of: providing a bioresorbable body having a radiopaque marker carried by the bioresorbable body, said bioresorbable body comprising polylactic acid; removing a biopsy specimen from the breast of a patient, thereby creating a biopsy site; inserting the bioresorbable body into the biopsy site to mark the location of the biopsy site; and testing the biopsy specimen.

### Claim 75 (depends on 74)

The method of claim 74, wherein the bioresorbable body further comprises polyglycolic acid.

### Claim 76

A target tissue localization device comprising: an elongate tubular member having a proximal end, a distal end, and a lumen therebetween; a bioresorbable body contained within the elongate tubular member, the bioresorbable body comprising polyglycolic acid; and a radiopaque marker carried by the bioresorbable body.

### Claim 77

A method for marking a biopsy cavity comprising the steps of: providing a bioresorbable body having a radiopaque marker carried by the bioresorbable body, said bioresorbable body comprising polyglycolic acid; removing a biopsy specimen from the breast of a patient, thereby creating a biopsy site; inserting the bioresorbable body into the biopsy site to mark the location of the biopsy site; and testing the biopsy specimen.

### Claim 78

An intracorporeal site marker for marking a selected site within tissue of a patient's body, comprising:
(a) an ultrasound detectable body including boundaries having a high contrast in acoustical impedance when the marker is placed in tissue of the selected site, so as to efficiently reflect ultrasound during ultrasound imaging; and
(b) a body shape which is recognizably artificial when the marker is subject to ultrasound or X-ray imaging, so as to be readily distinguishable from biological features within the tissue site.

### Claim 79

A remotely imageable marker for marking a selected intracorporeal site within a patient, comprising: (a) an ultrasound detectable body; and (b) a radiopaque marker element carried by the ultrasound detectable body on an exterior portion thereof.

### Claim 80 (depends on 79)

The remotely imageable marker of claim 79, wherein the ultrasound detectable body is formed at least in part of a material selected from the group consisting of gelatin, collagen, cross-linked collagen, polymeric material, and mixtures and composites thereof.

### Claim 81 (depends on 79)

The remotely imageable marker of claim 79, wherein the radiopaque marker element is a metallic band disposed at least partially surrounding the ultrasound detectable body.

### Claim 82 (depends on 81)

The remotely imageable marker of claim 81, wherein the metallic band is recognizably artificial when the marker is subject to ultrasound or X-ray imaging, so as to be readily distinguishable from biological features within the tissue site.

### Claim 83

A method of marking a selected intracorporeal tissue site for subsequent location, comprising: (a) providing at least one marker having an ultrasound detectable body and a radiopaque marker element carried by the ultrasound detectable body on an exterior portion thereof; and (b) implanting the marker at a preselected target site, so that the body is detectable when subject to ultrasound imaging.

### Claim 84 (depends on 83)

The method of claim 83, wherein implanting at least one marker includes inserting the marker through a biopsy needle device which has been previously inserted into the tissue site in the course of a biopsy procedure.

### Claim 85 (depends on 84)

The method of claim 84, wherein inserting the at least one marker through a biopsy needle device includes: (a) using a vacuum-assisted large core biopsy device as the biopsy needle device; and (b) the insertion of the marker includes: (i) loading the marker into a marker applicator device having an elongated marker insertion tube for holding the marker, the tube having a distal tip and a piston housed within the tube for expelling the marker from the tip; (ii) inserting the marker insertion tube through the large core biopsy device until the tip is adjacent the tissue site; and (iii) depressing the piston to expel the at least one marker from the tube to implant adjacent the tissue site.
